Recipient of federal assistance · BROOKLYN, NY

PHOENIX NEST INC

PHOENIX NEST INC received $1.5M in federal grants and other assistance in FY2026, on 4 actions, +40% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $12.4M. Its largest awarding agency was National Institutes of Health ($1.5M).

Assistance · FY2026
$1.5M
New awards
1
Actions
4
Since FY2021
$12.4M
UEI
C43HHASBLCV6
Location
BROOKLYN, NY
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 370.3KFY2021
  2. 5.1MFY2022
  3. 2.6MFY2023
  4. 1.8MFY2024
  5. 1.1MFY2025
  6. 1.5MFY2026

By type

  1. Grants$1.5M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders$1.5M100%

Awarding agencies

  1. National Institutes of Health$1.5M100%
    Department of Health and Human Services

Largest awards

  1. EVALUATION OF CLINICAL OUTCOME ASSESSMENT (COA) AND POTENTIAL BIOMARKERS TO FACILITATE INTERVENTIONALTRIAL FOR MUCOPOLYSACCHARIDOSIS IIID…$3.5M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Cooperative agreement· Sep 21, 2021 – May 5, 2026· UB1NS122644
  2. DEVELOPMENT OF GENE REPLACEMENT THERAPY FOR SANFILIPPO SYNDROME TYPE C - PROJECT SUMMARY/ABSTRACT LYSOSOMAL STORAGE DISEASES (LSD) ARE RARE…$3M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Sep 19, 2022 – Feb 28, 2026· R44NS129393
  3. IDENTIFICATION OF POTENTIAL BIOMARKERS AND CLINICAL TOOLS FOR USE IN MUCOPOLYSACCHARIDOSIS IIIC PATIENTS. - PROJECT SUMMARY/ABSTRACT…$1.9M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Jul 1, 2024 – Aug 12, 2026· R44NS137892
  4. MANUFACTURING AND ANALYTICAL DEVELOPMENT FOR JLK-247 GENE THERAPY - PROJECT SUMMARY/ABSTRACT LYSOSOMAL STORAGE DISEASES (LSD) ARE RARE AND…$1.5M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Jul 14, 2026 – Jul 14, 2026· R44NS147802

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.